These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19644947)

  • 21. Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler.
    Arakaki T; Hasegawa J; Nakamura M; Hamada S; Muramoto M; Takita H; Ichizuka K; Sekizawa A
    Ultrasound Obstet Gynecol; 2015 May; 45(5):539-43. PubMed ID: 25042564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.
    Leal AM; Poon LC; Frisova V; Veduta A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):135-41. PubMed ID: 19173240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
    Tayyar A; Guerra L; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):689-97. PubMed ID: 25594620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
    Akolekar R; Minekawa R; Veduta A; Romero XC; Nicolaides KH
    Prenat Diagn; 2009 Aug; 29(8):753-60. PubMed ID: 19412915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal venous Doppler characteristics are abnormal in pre-eclampsia but not in gestational hypertension.
    Gyselaers W; Staelens A; Mesens T; Tomsin K; Oben J; Vonck S; Verresen L; Molenberghs G
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):421-6. PubMed ID: 24890401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation.
    Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A
    Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Kuhnreich I; Meiri H
    Prenat Diagn; 2007 Mar; 27(3):258-63. PubMed ID: 17278173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population.
    Hafner E; Metzenbauer M; Höfinger D; Stonek F; Schuchter K; Waldhör T; Philipp K
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):652-7. PubMed ID: 16514618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal fraction of cell free DNA in screening for hypertensive disorders at 11-13 weeks.
    Sapantzoglou I; Gallardo Arozena M; Dragoi V; Akolekar R; Nicolaides KH; Syngelaki A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5363-5368. PubMed ID: 33517808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of first trimester uterine arteries Doppler velocimetry with different clinical phenotypes of hypertensive disorders of pregnancy: a longitudinal study.
    Stampalija T; Monasta L; Di Martino DD; Quadrifoglio M; Lo Bello L; D'Ottavio G; Zullino S; Mastroianni C; Casati D; Signorelli V; Rosti E; Cecotti V; Ceccarello M; Ferrazzi E
    J Matern Fetal Neonatal Med; 2019 Apr; 32(7):1191-1199. PubMed ID: 29157099
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality assessment of uterine artery Doppler measurement in first-trimester combined screening for pre-eclampsia.
    Rolnik DL; da Silva Costa F; Sahota D; Hyett J; McLennan A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):245-250. PubMed ID: 29917286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine artery Doppler at 30-33 weeks' gestation in the prediction of preeclampsia.
    Lai J; Poon LC; Pinas A; Bakalis S; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):156-63. PubMed ID: 23445882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing quality standards in measurement of uterine artery pulsatility index at 11 to 13 + 6 weeks' gestation.
    Ridding G; Hyett JA; Sahota D; McLennan AC
    Ultrasound Obstet Gynecol; 2015 Sep; 46(3):299-305. PubMed ID: 25412757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester prediction of hypertensive disorders in pregnancy.
    Poon LC; Kametas NA; Maiz N; Akolekar R; Nicolaides KH
    Hypertension; 2009 May; 53(5):812-8. PubMed ID: 19273739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.